john karwoski, rph, mba jdj consulting, llc [email protected] 03.19.2014

26
John Karwoski, RPh, MBA JDJ Consulting, LLC [email protected] 03.19.2014

Upload: jason-walsh

Post on 16-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

John Karwoski, RPh, MBAJDJ Consulting, LLC

[email protected]

Page 2: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014
Page 3: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Buying Group Yes or No, Group Name

Yes HPG

Yes Broadlane

Yes Med Assets

Yes HPG

Yes PSS

Yes Med Assets

Yes Novation/Med Assets

Yes Broadlane/Med Assets

Yes Med Assets

Yes Provista

Yes Provista

Page 4: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Ofirmev on Formulary Yes or No

Yes NoYesYesNoNoNoNoNoNoNo

Page 5: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Caldolor on Formulary Yes or No

Yes NoNoNoNoNoNoNoNoNoNo

Page 6: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Yes NoYesYesNoNoNoN/AN/AN/AN/A

Page 7: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

NoNoNoNoNoNoNoNoNoNoNo

Page 8: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

NoNoNoNoNoNoNoNoNoNoNo

Page 9: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Acquisition Costs:

Selected Drugs

Page 10: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Not Given$6.47$8.00$2.36$3.34$3.98$2.19$6.47$6.59

$32.37/Box 5$2.43

Page 11: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Not Given$1.05$4.00$0.36N/A

$0.72$0.42$1.08$0.55

11.08/Box25N/A

Page 12: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Not Given$0.30$1.40$1.42$0.49$0.53N/A

$1.42$2.80

22.53/Box 25100mg/ml $.90

Page 13: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Most drug cost comes directly off the bottom line

Page 14: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Drivers of Drug CostNew TechnologyNew pharmaceutical are more costly than

the older version – ARE THEY WORTH THE COST?

P and T must review the data to determine the relative effectiveness, relative toxicity, relative cost and relative benefit.

Some are worth it and some are not but you need to analyze

Page 15: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Drivers of Drug CostNew technologyContract complianceInefficient purchasingInefficient processingWastePackaging and unit sizePhysician preferenceAdverse events

Page 16: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Drug CostDrug Cost Components

AWP – what is cost?Contract with buying groupContract with wholesalerWastageOut datesOverchargesBilling ErrorsInventory Management

Page 17: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Inefficient PurchasingInjectionsZofran $10.44 vs. Ondansetron $0.76

Lanoxin  $3.06 vs. digoxin inj $1.70

Zantac $ 3.91 vs. ranitidine $0.95

Lopresson $14.00 vs. metoprolol $1.43

Suprane Vendor 1 $193.24 vs. Suprane Vendor 2 $ 173.80

These are examples of findings from a recent JDJ review of ASC invoices

Page 18: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Drivers of Drug CostWholesaler overcharges – who

checksOutages- who is responsibleOutages – are you reimbursed for

themReverse distributor

Page 19: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Opportunities

Inventory Cost Wholesale contractBuying group contract

Page 20: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Management of Drug CostEfficient ManagementFormulary managementBuying GroupWholesaler contractUtilization of generics day 1Utilization of therapeutic interchangeCheck invoicesCharge backsReduce waste Inventory management

Page 21: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

Drug costWho is managing your drug cost?

Page 22: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014
Page 23: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

NoNoYesYesNoNoYesNoNoNoNo

Page 24: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

NoNoNoNoNoNoYesNoNoNoNo

Page 25: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014

NoNoNoNoNoNo

Based on BehaviorNoNoYesNo

Page 26: John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014